Dalian BIO-CHEM Company Limited (603360.SS)
CNY 26.09
(-10.0%)
CNY 26.09
(-10.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 389.68 Million | 479.9 Million | 142.02 Million | 210.61 Million | 240.06 Million | 135.13 Million |
| Net Income | 328.37 Million | 402.56 Million | 250.49 Million | 221.75 Million | 306.8 Million | 145.06 Million |
| Depreciation & Amortization | 64.04 Million | 70.92 Million | 48.13 Million | 42.41 Million | 35.02 Million | 24.14 Million |
| Deferred income taxes | -4.97 Million | 11.39 Million | 26.38 Million | -143.06 Thousand | 12.65 Million | 5.21 Million |
| Stock-based compensation | 15.46 Million | 8.47 Million | 6.14 Million | - | - | - |
| Change in working capital | -33.64 Million | -12.03 Million | -173.92 Million | -76.25 Million | -104.18 Million | -30.89 Million |
| Other non-cash items | 3.92 Million | -1.42 Million | -15.2 Million | 22.7 Million | 2.42 Million | -3.17 Million |
| Investing Cash Flow | -126.91 Million | -124.6 Million | -50.4 Million | -117.47 Million | -26.57 Million | -150.03 Million |
| Investments in PPE | -67.35 Million | -134.28 Million | -191.61 Million | -109.2 Million | -62.96 Million | -88.47 Million |
| Acquisitions | 100 Thousand | 12.24 Million | 15.65 Thousand | 50.00 | 63.04 Million | 88.47 Million |
| Investment purchases | -241.18 Million | 1.44 | -15.65 Thousand | -10 Million | -128.15 Million | -390 Million |
| Sales/Maturities of investments | 181.51 Million | 939.26 Thousand | 142.49 Million | -50.00 | 164.46 Million | 328.44 Million |
| Other Investing Activities | -59.56 Million | -3.51 Million | -1.28 Million | 1.72 Million | -62.96 Million | -88.47 Million |
| Financing Cash Flow | -188.16 Million | -170.85 Million | -58.65 Million | -154.63 Million | -45.17 Million | -34.28 Million |
| Debt repayment | -20.96 Million | -284.98 Million | -111.28 Million | -60 Million | -20 Million | -100 Million |
| Dividends payments | -202.89 Million | -6.49 Million | -150.14 Million | -112 Million | -72.8 Million | -34.28 Million |
| Common Stock Repurchased | -767.82 Thousand | - | -45.1 Million | -154.89 Million | - | - |
| Common Stock Issuance | - | - | 45.1 Million | 154.89 Million | - | - |
| Other Financing Activities | -2.26 Million | 120.62 Million | 211.64 Million | 18.29 Million | 49.99 Million | 100 Million |
| Accounts receivables | -9.48 Million | 43.07 Million | -120.15 Million | -72.28 Million | -120.45 Million | 3.61 Million |
| Accounts payables | 6.71 Million | -73.08 Million | 1.29 Million | 20.18 Million | 33.56 Million | -21.48 Million |
| Inventory | -25.89 Million | 6.58 Million | -81.45 Million | -24.01 Million | -29.94 Million | -18.24 Million |
| Other working capital | 15.46 Million | 11.39 Million | 26.38 Million | -143.06 Thousand | 12.65 Million | -12.64 Million |
| Cash at beginning of period | 395.37 Million | 211.14 Million | 178.7 Million | 240.24 Million | 71.6 Million | 121.4 Million |
| Cash at end of period | 473.38 Million | 395.37 Million | 211.14 Million | 178.7 Million | 240.24 Million | 71.6 Million |
| Capital Expenditure | -67.35 Million | -134.28 Million | -191.61 Million | -109.2 Million | -62.96 Million | -88.47 Million |
| Effect of forex changes on cash | 3.4 Million | -201.87 Thousand | -526.65 Thousand | -41.99 Thousand | 315.64 Thousand | -607.1 Thousand |
| Net cash flow / Change in cash | 78 Million | 184.23 Million | 32.44 Million | -61.53 Million | 168.63 Million | -49.79 Million |
| Free Cash Flow | 322.33 Million | 345.61 Million | -49.58 Million | 101.41 Million | 177.1 Million | 46.65 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 89.67 Million | 66.23 Million | 98.31 Million | 328.37 Million | 45.43 Million | 93.07 Million |
| Depreciation & Amortization | - | 16.71 Million | 16.71 Million | 64.04 Million | 64.04 Million | 16.1 Million |
| Deferred income taxes | - | - | - | -4.97 Million | - | - |
| Stock-based compensation | - | - | - | 15.46 Million | 15.46 Million | - |
| Change in working capital | - | - | - | -33.64 Million | -19.91 Million | - |
| Other non-cash items | 88.66 Million | 62.61 Million | -152.03 Million | 3.92 Million | -21.36 Million | -7.79 Million |
| Investing Cash Flow | -165.63 Million | 33.05 Million | -14.91 Million | -126.91 Million | -66.95 Million | -7.93 Million |
| Investments in PPE | -28.14 Million | -5.84 Million | -14.64 Million | -67.35 Million | -7.28 Million | -7.93 Million |
| Acquisitions | 3.1 Million | 28.04 Million | - | 100 Thousand | - | - |
| Investment purchases | -140 Million | -35.54 Million | - | -241.18 Million | -241.18 Million | - |
| Sales/Maturities of investments | - | 95.54 Million | - | 181.51 Million | 181.18 Million | - |
| Other Investing Activities | -602.86 Thousand | -50.07 Million | -270 Thousand | -59.56 Million | -59.66 Million | - |
| Financing Cash Flow | -50.68 Million | -197.51 Million | 97.7 Million | -188.16 Million | -29.05 Million | 46.85 Million |
| Debt repayment | -49.84 Million | -5 Million | -50 Million | -20.96 Million | -19.96 Million | -49 Million |
| Dividends payments | - | -218.13 Million | -1.97 Million | -202.89 Million | -202.89 Million | -1.42 Million |
| Common Stock Repurchased | - | - | - | -767.82 Thousand | -767.82 Thousand | 607.92 Thousand |
| Common Stock Issuance | - | - | - | - | - | -607.92 Thousand |
| Other Financing Activities | -837.29 Thousand | 15.61 Million | 49.67 Million | -2.26 Million | -48.93 Million | 97.27 Million |
| Accounts receivables | - | - | - | -9.48 Million | -9.48 Million | - |
| Accounts payables | - | - | - | 6.71 Million | - | - |
| Inventory | - | - | - | -25.89 Million | -25.89 Million | - |
| Other working capital | - | - | - | 15.46 Million | 15.46 Million | - |
| Cash at beginning of period | 454.63 Million | 503.24 Million | 473.38 Million | 395.37 Million | 499.2 Million | 373.48 Million |
| Cash at end of period | 418.17 Million | 454.63 Million | 503.24 Million | 473.38 Million | 473.38 Million | 499.2 Million |
| Capital Expenditure | -28.14 Million | -5.84 Million | -14.64 Million | -67.35 Million | -7.28 Million | -7.93 Million |
| Effect of forex changes on cash | - | 4.63 Million | 783.62 Thousand | 3.4 Million | 1.99 Million | 1.52 Million |
| Net cash flow / Change in cash | -36.45 Million | -48.61 Million | 29.85 Million | 78 Million | -25.81 Million | 125.72 Million |
| Free Cash Flow | 150.19 Million | 106.29 Million | -68.36 Million | 322.33 Million | 60.92 Million | 77.34 Million |
4716
6150
ASHM
BOW
SKFRY
EPC